(FOX 46 WJZY) – A large medication recall has expanded again – now to a global scale.
Valsartan, a prescription medication commonly used to treat blood pressure issues and heart failure, is now under a worldwide recall.
The U.S. Food and Drug Administration says the drug contains a cancer causing chemical called N-nitrosodimethylamine (NDMA). This chemical is toxic to the liver and other organs.
“The presence of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured,” the FDA said.
When the initial recall was first announced a few weeks ago, it didn’t include the United States and it just impacted the generic version.
“We have carefully assessed the valsartan-containing medications sold in the United States, and we’ve found that the valsartan sold by these specific companies does not meet our safety standards. This is why we’ve asked these companies to take immediate action to protect patients,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research.
Now, the recall has gone global with the FDA adding three new manufacturers to the list:
- Valsartan – Major Pharmaceuticals
- Valsartan – Solco Healthcare
- Valsartan – Teva Pharmaceuticals Industries Ltd.
- Valsartan/Hydrochlorothiazide (HCTZ) – Solco Healthcare
- Valsartan/Hydrochlorothiazide (HCTZ) – Teva Pharmaceuticals Injustries Ltd.
For more information on this recall, click here.
[ktzagcplugin_text source=”bing” number=”4″ related=”true”]